Skip to main content

MapLight Therapeutics, Inc.

MPLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001770069

In the last 90 days, MapLight Therapeutics, Inc. insiders filed 3 open-market purchases and 8 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $941.0M in total; no superinvestor holds it.

Superinvestors holding MPLT, Q2 2026

See all superinvestors

No superinvestor reported holding MPLT in Q2 2026.